Tag: heart

Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk...

Three million prescriptions for Wegovy® pill since launch on January 5th serves as another milestone in one of the strongest US pharmaceutical launches by...

A New Era Begins: Cal Poly Unveils the John Madden Football Center

$45 Million Facility Honors Legendary Alumnus and Elevates the Future of Mustang FootballSAN LUIS OBISPO, Calif., June 6, 2026 /PRNewswire/ -- Cal Poly Athletics...

From Bystanders to Heart Savers: MedStar Health CPR Training Event Puts Power to Save Lives in Community’s Hands

SILVER SPRING, Md., June 6, 2026 /PRNewswire/ -- MedStar Health marked CPR & AED Awareness Week with its third annual training event held at...

Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity

Findings highlight use of once-weekly injection to expand potential options for weight reduction, A1C control, knee osteoarthritis, and obstructive sleep apneaNEW ORLEANS, June 6,...

Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association’s 2026 Scientific Sessions

Post hoc analyses explored the impact of semaglutide across an array of conditions including obstructive sleep apnea (OSA), asthma-related adverse outcomes, liver health, cardiometabolic...

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with...

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and AID Use

Corner Bakery Offers $50 Off Catering for Game-Day Watch Parties

Limited-time June offer helps fans feed the crowd during watch parties, game days and summer gatherings.DALLAS, June 5, 2026 /PRNewswire/ -- June is packed...

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

Phase 2 Study Results Highlight Use of Once-Daily Injection for Weight Loss and Reduction in Insulin UseNEW ORLEANS, June 5, 2026 /PRNewswire/ -- A...

MICHAEL FEINSTEIN CELEBRATES PRIDE MONTH WITH THE RELEASE OF NEW ANTHEM “GAYMEN” LEAD VOCALS BY motherfather, FEATURING A SPECIAL APPEARANCE BY LIZA MINNELLI

Michael Feinstein and Bobby Daye Unveil FeinDaye, a New Creative Venture Bridging Music, Entertainment and Live ExperiencesLOS ANGELES, June 5, 2026 /PRNewswire/ -- Acclaimed...

With a record 56 teams signed up, innovation, energy and the future of navigation are set to converge on the 2026 Monaco Energy Boat Challenge

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsHeart

Robbins LLP Reminds CVLT Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action...

Teen-Founded Nonprofit Busy Buzzy Bots Reaches 11,000+ Kids Through STEM Education–and It Is Just Getting Started

FDA approves Lilly’s EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

Tag: heart

Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk...

A New Era Begins: Cal Poly Unveils the John Madden Football Center

From Bystanders to Heart Savers: MedStar Health CPR Training Event Puts Power to Save Lives in Community’s Hands

Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity

Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association’s 2026 Scientific Sessions

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with...

Corner Bakery Offers $50 Off Catering for Game-Day Watch Parties

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

MICHAEL FEINSTEIN CELEBRATES PRIDE MONTH WITH THE RELEASE OF NEW ANTHEM “GAYMEN” LEAD VOCALS BY motherfather, FEATURING A SPECIAL APPEARANCE BY LIZA MINNELLI

Sagamité to Open a Restaurant and Shop at YQB

Platypus Home Celebrates Grand Reopening Under New Ownership With a Reimagined Showroom

St. Joseph’s Children’s Hospital Cancer Survivor Advocates for Children’s Health Care on Capitol Hill

SUBARU EARNS NINE SPOTS ON IIHS AND CONSUMER REPORTS 2026 TEEN DRIVER VEHICLE RECOMMENDATION LIST

13th Monaco Energy Boat Challenge 8-11 July 2026 Monaco as a global laboratory for sustainable yachting

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us